Compounds that exhibit a covalent mechanism of action are typically avoided in drug discovery programmes, largely owing to safety concerns. Here, Singh and colleagues present the pharmacological advantages offered by covalent drugs and discuss strategies to address the potential risks and challenges that have been associated with these agents.
- Juswinder Singh
- Russell C. Petter
- Adrian Whitty
